VB
Publicaties op Oncologisch.com
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Behandeling of Patients with Unresectable or Metastatic, HR-Pos...
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Rece...
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant...
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Behandeling of Adult Patiënten met H...
FDA-goedkeuring van capivasertib plus fulvestrant bij mammacarcinoom
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.
FDA-goedkeuring van olaparib plus abiraterone bij BRCA-gemuteerd mCRPC